APA (7th ed.) Citation

Petranović Ovčariček, P., de Keizer, B., Campennì, A., Kreissl, M. C., Deandreis, D., Tuncel, M., & Giovanella, L. (2025). Radioiodine-refractory thyroid cancer—is it time to change the definition in light of novel redifferentiation therapies? European Journal of Nuclear Medicine & Molecular Imaging, 52(2), 380. https://doi.org/10.1007/s00259-024-06991-5

Chicago Style (17th ed.) Citation

Petranović Ovčariček, Petra, Bart de Keizer, Alfredo Campennì, Michael C. Kreissl, Desiree Deandreis, Murat Tuncel, and Luca Giovanella. "Radioiodine-refractory Thyroid Cancer—is It Time to Change the Definition in Light of Novel Redifferentiation Therapies?" European Journal of Nuclear Medicine & Molecular Imaging 52, no. 2 (2025): 380. https://doi.org/10.1007/s00259-024-06991-5.

MLA (9th ed.) Citation

Petranović Ovčariček, Petra, et al. "Radioiodine-refractory Thyroid Cancer—is It Time to Change the Definition in Light of Novel Redifferentiation Therapies?" European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 2, 2025, p. 380, https://doi.org/10.1007/s00259-024-06991-5.